Federal Register #2026-17273

DEA Notice: Biopharmaceutical Research Company Application for Bulk Manufacture of Schedule I Controlled Substances

The Drug Enforcement Administration (DEA), under the Department of Justice, has announced a notice regarding Biopharmaceutical Research Company's application to become a registered bulk manufacturer of Schedule I controlled substances. - Government Buyer: - Drug Enforcement Administration (DEA), Department of Justice - OEM/Vendor: - Biopharmaceutical Research Company - Products/Services Requested: - Bulk manufacturing of Schedule I controlled substances: - Marihuana Extract (Drug Code 7350) - Marihuana (Drug Code 7360) - Tetrahydrocannabinols (Drug Code 7370) - Quantities: - Not specified; registration covers authorization to manufacture - Unique/Notable Requirements: - Manufacture is limited to pharmaceutical-grade marihuana for research purposes - Compliance with local, state, and federal regulations is required - No other activities for these drug codes are authorized under this registration - Public comments or objections are invited from registered bulk manufacturers and applicants

Description

Biopharmaceutical Research Company has applied to be registered as a bulk manufacturer of basic classes of controlled substances, including Marihuana Extract, Marihuana, and Tetrahydrocannabinols, all Schedule I substances. The company plans to bulk manufacture these controlled substances to provide pharmaceutical-grade marihuana to facilitate research in compliance with local, state, and federal regulations. Comments or objections to the issuance of the proposed registration may be submitted electronically by registered bulk manufacturers and applicants by October 26, 2026. Written requests for a hearing on the application may also be filed by the same date.

View original listing